Investigation of XCell ATF® Perfusion Technology for virus manufacturing process intensification at MSD Animal Health
Transforming Vaccine Manufacturing: The XCell ATF® Perfusion Breakthrough
Discover how MSD Animal Health enhanced virus production efficiency with Repligen’s cutting-edge technology.
Dive into the heart of bioprocessing innovation with our latest white paper. Here, MSD Animal Health and Repligen collaborate to showcase the transformative potential of XCell ATF® Perfusion Technology in animal vaccine production. Through extensive experimentation, they found a five-fold increase in both cell density and viral output, marking a significant advance over traditional batch processes. This technology not only maximizes manufacturing efficiency but also brings scalability and product quality improvements, illustrating a game-changing approach for the vaccine industry.
Download now to explore how this scalable solution can address your manufacturing challenges.
White Paper from 